COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,001 Articles (22,627 medRxiv, 8,374 bioRxiv)

Most recent first Previous |  Page 1703: Articles 17021-17030  | Next

Novel inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
Amporndanai, K., Meng, X., Yang, H., Liu, Z.-J., Zhang, L., Zhao, Y., Hasnain, S., O'Neill, P., Rao, Z., Jin, Z., Shang, W.
10.1101/2021.03.11.434764 — Posted: 2021-03-11
SARS-CoV-2 comprehensive receptor profiling: mechanistic insight to drive new therapeutic strategies
Brockbank, S. M., Faba-Rodriguez, R., Rosenbrier Ribeiro, L., Geh, C., Thomas, H., Delight, J., Coverley, L., Abbott, W. M., Soden, J., Freeth, J.
10.1101/2021.03.11.434937 — Posted: 2021-03-11
Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva
Ketas, T. J., Chaturbhuj, D., Cruz Portillo, V., Francomano, E., Golden, E., Chandrasekhar, S., Debnath, G., Diaz Tapia, R., Yasmeen, A., Leconet, W., Zhao, Z., Brouwer, P. J. M., Cushing, M. M., Sanders, R., Cupo, A., Klasse, P. J., Formenti, S. C., Moore, J. P.
10.1101/2021.03.11.434841 — Posted: 2021-03-11
A tandem-repeat dimeric RBD protein-based COVID-19 vaccine ZF2001 protects mice and nonhuman primates
An, Y., Li, S., Jin, X., Han, J.-B., Xu, K., Xu, S., Han, Y., Liu, C., Zheng, T., Liu, M., Yang, M., Song, T.-z., Huang, B., Zhao, L., Wang, W., A, R., Cheng, Y., Wu, C., Huang, E., Yang, S., Wang, G., Bi, Y., Ke, C., Tan, W., Yan, J., Zheng, Y.-T., Dai, L., Gao, G. F.
10.1101/2021.03.11.434928 — Posted: 2021-03-11
Spike vs nucleocapsid SARS-CoV-2 antigen detection: application in nasopharyngeal swab specimens
Barlev-Gross, M., Weiss, S., Ben-Shmuel, A., Sittner, A., Eden, K., Mazuz, N., Glinert, I., Bar-David, E., Puni, R., Amit, S., Kriger, O., Schuster, O., Alcalay, R., Makdasi, E., Epstein, E., Noy-Porat, T., Rosenfeld, R., Achdout, H., Mazor, O., Israely, T., Levy, H., Mechaly, A.
10.1101/2021.03.08.21253148 — Posted: 2021-03-11
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike
Tong, P., Gautam, A., Windsor, I., Travers, M., Chen, Y., Garcia, N., Whiteman, N., McKay, L., Lelis, F. J. N., Habibi, S., Cai, Y., Rennick, L. J., Duprex, W. P., McCarthy, K., Lavine, C. L., Zuo, T., Lin, J., Zuiani, A., Feldman, J., MacDonald, E. A., Hauser, B. M., Griffths, A., Seaman, M. S., Schmidt, A. G., Chen, B., Neuberg, D., Bajic, G., Harrison, S. C., Wesemann, D. R.
10.1101/2021.03.10.434840 — Posted: 2021-03-10
Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response
Nguyen, L. C., Yang, D., Nicolaescu, V., Best, T., Chen, S., Friesen, J. B., Drayman, N., Mohamed, A., Dann, C., Silva, D., Gula, H., Jones, K. A., Millis, J. M., Dickinson, B. C., Tay, S., Oakes, S. A., Pauli, G. F., Meltzer, D. O., Randall, G., Rosner, M. R.
10.1101/2021.03.10.432967 — Posted: 2021-03-10 Discussion: Onsite
The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2
Cathcart, A. L., Havenar-Daughton, C., Lempp, F. A., Ma, D., Schmid, M., Agostini, M. L., Guarino, B., Di iulio, J., Rosen, L., Tucker, H., Dillen, J., Subramanian, S., Sloan, B., Bianchi, S., Wojcechowskyj, J., Zhou, J., Kaiser, H., Chase, A., Montiel-Ruiz, M., Czudnochowski, N., Cameroni, E., Ledoux, S., Colas, C., Soriaga, L., Telenti, A., Hwang, S., Snell, G., Virgin, H. W., Corti, D., Hebner, C. M.
10.1101/2021.03.09.434607 — Posted: 2021-03-10
Development of Equine Immunoglobulin Fragment F(ab')2 with High Neutralizing Capability against SARS-CoV-2
Gupta, D., Ahmed, F., Tandel, D., Parthasarathy, H., Vedagiri, D., Sah, V., Bodduluru, K. M., Daga, S. S., Khan, R. A., Kondiparthi, C., Savari, P., Jain, S. H., Daga, J. S., Reddy, S., Khan, N., Harshan, K. H.
10.1101/2021.03.09.434030 — Posted: 2021-03-10
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes
Sun, D., Sang, Z., Kim, J., Xiang, Y., Cohen, T., Belford, A. K., Huet, A., Conway, J. F., Sun, J., Taylor, D., Zhang, C., Huang, W., Shi, Y.
10.1101/2021.03.09.434592 — Posted: 2021-03-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).